SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Selectis Health, Inc. – ‘8-K’ for 8/18/20

On:  Monday, 8/24/20, at 4:32pm ET   ·   For:  8/18/20   ·   Accession #:  1493152-20-16615   ·   File #:  0-15415

Previous ‘8-K’:  ‘8-K’ on 8/14/20 for 8/7/20   ·   Next:  ‘8-K’ on 10/1/20 for 9/29/20   ·   Latest:  ‘8-K’ on 3/25/24 for 3/18/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/24/20  Global Healthcare REIT, Inc.      8-K:8       8/18/20    1:26K                                    M2 Compliance LLC/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     14K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 18, 2020

 

GLOBAL HEALTHCARE REIT, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Utah   0-15415   87-0340206

(State or other jurisdiction

of incorporation)

 

Commission

File Number

 

(I.R.S. Employer

Identification number)

 

6800 N. 79th St., Ste. 200, Niwot, CO 80503

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (303) 449-2100

 

 

 

(Former name or former address, if changed since last report)

 

[  ] Written communications pursuant to Rule 425 under the Securities Act
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on
which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 C: 
 
 

 

ITEM 8.01 OTHER EVENTS

 

On August 18, 2020, Global Healthcare REIT’s (the “Company”) Board of Directors approved the repurchase of 443,431 shares of common stock for $75,385 or $0.17 per share in a privately negotiated transaction. The Company intends to cancel the repurchased shares so they are no longer outstanding.

 

“Despite uncertainty surrounding nursing homes amidst the Covid-19 virus, we believe the market price for our stock is significantly undervalued,” stated Zvi Rhine, Global’s President and Chief Financial Officer. “We continue to refine our capital allocation priorities as our cash flow continues to improve. However, our first priority is to maintain adequate cash and flexibility to properly support our growing healthcare service business.”

 

 C: 
 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

Global Healthcare REIT, Inc.

(Registrant)

     
Dated: August 24, 2020 /s/ Zvi Rhine
    Zvi Rhine, President

 

 C: 
 

 


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on:8/24/20None on these Dates
For Period end:8/18/20
 List all Filings 
Top
Filing Submission 0001493152-20-016615   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 1:40:52.1am ET